Business Imperatives

  • A French multinational pharmaceutical company, headquartered in Paris, engaged Freyr to conduct GxP compliance audits for its vendors. 
  • The audits encompassed the evaluation of vendor service facilities, vendor manufacturing facilities, and the processes and inter-relationship between the parent company and vendors. 
  • They sought Freyr due to their lack of in-house expertise in GxP service requirements and compliance. 

Objectives

Support was required for GxP compliance audits for its vendors that include auditing of:  

  • Vendor service facilities 
  • Vendor manufacturing facilities 
  • Processes and inter-relationships between the parent company and vendors 

Problem Statement

  • The customer lacked a developed or in-use management system to oversee the current system and services. 
  • There was a lack of in-house expertise to perform GxP audits. 
  • The audit plan scope had to be changed due to changing customer requirements, leading to a change of sites. 
  • Many vendors were spread across the globe, posing logistical challenges.  

Freyr Solutions and Services

 Freyr Solutions and Services
  • An audit calendar was prepared. 
  • Audit specialists were assigned based on GxP. 
  • Auditors were trained in customer-specific audit processes and templates. 
  • Periodic status reports were provided to the parent company. 
  • The on-site audit model was converted to a remote audit model during COVID-19 to ensure audits were conducted according to the audit calendar. 
  • Audit Checklist: Created a checklist based on Regulatory requirements, industry best practices, and internal quality standards. 
  • Schedule Audit: Coordinate with the auditee to schedule the audit at a mutually convenient time. 
  • Perform Audit: Conducted the audit according to the predetermined checklist. Interviewed personnel, observed processes, and reviewed documentation to assess compliance with GxP requirements.  
  • Communicate Audit Findings: Held an exit meeting with the auditee to discuss preliminary findings and observations. Provided an opportunity for the auditee to respond to findings and clarify any discrepancies. 
  • Prepare Audit Report: Documented audit findings, including observations, non-conformities, and areas of improvement, in a comprehensive audit report.  
  • Achieving 100% GDP compliance, adhering strictly to all the guidelines.  
  • Business continuity during pandemic 
  • Support was provided for GxP compliance audits for the vendors, covering auditing of vendor service facilities, vendor manufacturing facilities, processes and inter-relationships between the parent company and vendors. 
  • Comprehensive audits were successfully conducted, ensuring adherence to Regulatory standards across all vendor operations. 
  • Identified areas for improvement and optimization in vendor operations to enhance overall compliance and quality standards within the pharmaceutical supply chain.